Literature DB >> 25026244

The frequency of Th17 and Th22 cells in patients with colorectal cancer at pre-operation and post-operation.

Limian Ling1, Pingwei Zhao, Guoqiang Yan, Mingxiao Chen, Ting Zhang, Lei Wang, Yanfang Jiang.   

Abstract

T helper 17 (Th17) and Th22 cells regulate the development of tumors. However, their roles in the development of colorectal cancer (CRC) are still unclear. A total of 49 patients with CRC and 18 healthy controls (HC) were evaluated for the percentages of circulating Th17 and Th22 cells by flow cytometry. The concentrations of serum interleukin-17A (IL-17A), IL-22 and carcinoembryonic antigen (CEA) were examined. The levels of IL-17A and IL-22 in tumors were determined by real-time PCR. We found that the percentages of Th17 and Th22 cells in the CRC patients were significantly lower than that in the HC and were associated negatively with the pathological stages of CRC. The levels of IL-17A and IL-22 mRNA transcripts were lower in the tumor tissues, particularly in the advanced CRC. After the tumor resection, the percentages of circulating Th17 and Th22 cells increased. These data suggest that decreased Th17 and Th22 responses may be associated with the development of CRC.

Entities:  

Keywords:  Colorectal cancer; IL-17A; IL-22; Th17; Th22; peri-operative period

Mesh:

Substances:

Year:  2014        PMID: 25026244     DOI: 10.3109/08820139.2014.936445

Source DB:  PubMed          Journal:  Immunol Invest        ISSN: 0882-0139            Impact factor:   3.657


  8 in total

1.  Functional impairment of infiltrating T cells in human colorectal cancer.

Authors:  Edward S Taylor; John L McCall; Adam Girardin; Fran M Munro; Michael A Black; Roslyn A Kemp
Journal:  Oncoimmunology       Date:  2016-09-26       Impact factor: 8.110

2.  Recruitment and significance of Th22 cells and Th17 cells in malignant ascites.

Authors:  Xian-Wen Yang; Hai-Xing Jiang; Ronge Lei; Wei-Shun Lu; Shi-Hui Tan; Shan-Yu Qin
Journal:  Oncol Lett       Date:  2018-08-16       Impact factor: 2.967

3.  TGF-β signaling in Th17 cells promotes IL-22 production and colitis-associated colon cancer.

Authors:  Richard A Flavell; Samuel Huber; Laura Garcia Perez; Jan Kempski; Heather M McGee; Penelope Pelzcar; Theodora Agalioti; Anastasios Giannou; Leonie Konczalla; Leonie Brockmann; Ramez Wahib; Hao Xu; Maria Carolina Amezcua Vesely; Shiwa Soukou; Babett Steglich; Tanja Bedke; Carolin Manthey; Oliver Seiz; Björn-Philipp Diercks; Stylianos Gnafakis; Andreas H Guse; Daniel Perez; Jakob R Izbicki; Nicola Gagliani
Journal:  Nat Commun       Date:  2020-05-25       Impact factor: 14.919

Review 4.  TH9, TH17, and TH22 Cell Subsets and Their Main Cytokine Products in the Pathogenesis of Colorectal Cancer.

Authors:  Guanglin Cui
Journal:  Front Oncol       Date:  2019-10-04       Impact factor: 6.244

5.  Perioperative changes in lymphocyte subpopulations in patients undergoing surgery for colorectal cancer.

Authors:  Mateusz Rubinkiewicz; Izabela Siemińska; Piotr Małczak; Piotr Major; Jarosław Baran; Andrzej Budzyński; Michał Pędziwiatr
Journal:  Acta Clin Croat       Date:  2019-06       Impact factor: 0.780

6.  Fusobacterium nucleatum promotes liver metastasis in colorectal cancer by regulating the hepatic immune niche and altering gut microbiota.

Authors:  Han Yin; Zhuangzhuang Miao; Lu Wang; Beibei Su; Chaofan Liu; Yu Jin; Bili Wu; Hu Han; Xianglin Yuan
Journal:  Aging (Albany NY)       Date:  2022-02-25       Impact factor: 5.682

7.  The Different Functional Distribution of "Not Effector" T Cells (Treg/Tnull) in Colorectal Cancer.

Authors:  Elena Niccolai; Federica Ricci; Edda Russo; Giulia Nannini; Giacomo Emmi; Antonio Taddei; Maria Novella Ringressi; Filippo Melli; Manouela Miloeva; Fabio Cianchi; Paolo Bechi; Domenico Prisco; Amedeo Amedei
Journal:  Front Immunol       Date:  2017-12-22       Impact factor: 7.561

8.  Differential gene expression of tumor-infiltrating CD4+ T cells in advanced versus early stage colorectal cancer and identification of a gene signature of poor prognosis.

Authors:  Varun Sasidharan Nair; Reem Saleh; Rowaida Z Taha; Salman M Toor; Khaled Murshed; Ayman A Ahmed; Mohamed A Kurer; Mohamed Abu Nada; Fares Al Ejeh; Eyad Elkord
Journal:  Oncoimmunology       Date:  2020-09-30       Impact factor: 8.110

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.